Clinical Trials Register

Trials with a EudraCT protocol (28,934)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

28,934 result(s) found for: Informed Consent. Displaying page 716 of 1,447.

EudraCT Number: 2011-000621-80

Sponsor Protocol Number: 212082BCA2001

Start Date*: 2011-08-01

Sponsor Name:Janssen-Cilag International NV

Full Title: Randomized, Open-Label Study of Abiraterone Acetate (JNJ-212082) Plus Prednisone With or Without Exemestane in Postmenopausal Women With ER+ Metastatic Breast Cancer Progressing After Letrozole or ...

Medical condition: Metastatic Breast Cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.0	100000004864	10027475	Metastatic breast cancer	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: BE (Completed) GB (Completed) ES (Completed) FR (Completed) NL (Prematurely Ended) IE (Completed) IT (Completed) PL (Prematurely Ended)

Trial results: View results

EudraCT Number: 2015-002067-41

Sponsor Protocol Number: 3475-158

Start Date*: 2016-01-14

Sponsor Name:Merck Sharp & Dohme LLC

Full Title: A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE 158)

Medical condition: -Anal Squamous Cell Carcinoma (CA)-Biliary Adenocarcinoma -Neuroendocrine Tumors (well-and moderately-differentiated) -Endometrial CA (sarcomas and mesenchymal tumors are excluded) -Cervical Squamo...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	100000004864	10065143	Malignant solid tumour	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned) GB (GB - no longer in EU/EEA) ES (Ongoing) DK (Trial now transitioned) NL (Trial now transitioned) FR (Trial now transitioned) IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2015-001775-41

Sponsor Protocol Number: UX023-CL304

Start Date*: 2015-12-16

Sponsor Name:Ultragenyx Pharmaceutical Inc.

Full Title: An Open-Label, Single-Arm, Phase 3 Study to Evaluate the Effects of KRN23 on Osteomalacia in Adults with X-linked Hypophosphatemia (XLH)

Medical condition: XLH is a disorder of hypophosphatemia, renal phosphate wasting, and the most common inheritable form of rickets. In XLH patients, excess circulating fibroblast growth factor (FGF23) impair phospha...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	100000004850	10016206	Familial hypophosphataemic rickets	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DK (Completed) FR (Completed)

Trial results: View results

EudraCT Number: 2008-006441-10	Sponsor Protocol Number: 116-02	Start Date*: 2009-06-03
Sponsor Name:SCIPHARM SáRL
Full Title: A double blind controlled clinical study to investigate the efficacy and tolerability of subcutaneous Treprostinil sodium in patients with severe non-operable Chronic Thromboembolic Pulmonary Hyper...
Medical condition: Patients with Severe (inoperable) Chronic Thromboembolic Pulmonary Hypertension
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: AT (Completed) CZ (Completed) SK (Completed) DE (Prematurely Ended)
Trial results: View results

EudraCT Number: 2017-002527-21	Sponsor Protocol Number: AMYPAD-01	Start Date*: 2018-05-23
Sponsor Name:University of Geneva
Full Title: Multicentre, Open-label, Randomised Study to Assess the Diagnostic Value of Amyloid PET Imaging in Patients with Subjective Cognitive Decline Plus, Mild Cognitive Impairment, or Dementia Where Alzh...
Medical condition: Alzheimer's disease Mild Cognitive Impairment Subjective Cognitive Decline Plus
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Ongoing) DE (Completed) ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2010-022548-19

Sponsor Protocol Number: TP-434-P2-cIAI-1

Start Date*: 2011-05-09

Sponsor Name:Tetraphase Pharmaceuticals, Inc.

Full Title: A Phase 2, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety and Pharmacokinetics of 2 Dose Regimens of TP-434 Compared with Ertapenem in Adult...

Medical condition: Community-acquired complicated intra-abdominal infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10021881 - Infections and infestations	10056570	Intra-abdominal infection	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LT (Completed) BG (Completed) LV (Completed)

Trial results: (No results available)

EudraCT Number: 2018-003553-19

Sponsor Protocol Number: IBCSG59-19/BIG18-02

Start Date*: 2019-06-25

Sponsor Name:International Breat Cancer Study Group (IBCSG)

Full Title: A phase III open-label, multicenter, randomized trial of adjuvant palbociclib in combination with endocrine therapy versus endocrine therapy alone for patients with hormone receptor positive / HER2...

Medical condition: patients with hormone receptor positive / HER2-negative resected isolated locoregional recurrence of breast cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006198	Breast cancer recurrent	PT
	20.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10070575	Estrogen receptor positive breast cancer	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing) FR (Trial now transitioned) HU (Trial now transitioned) AT (Trial now transitioned) IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2022-002267-29

Sponsor Protocol Number: WVE-004-002

Start Date*: 2022-10-14

Sponsor Name:Wave Life Sciences UK Limited

Full Title: A Multicenter, Open-label Extension (OLE) Study to Evaluate the Safety, Pharmacodynamics, and Clinical Effects of WVE-004 in Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and...

Medical condition: Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029205 - Nervous system disorders	10068968	Frontotemporal dementia	PT
	21.1	10029205 - Nervous system disorders	10002026	Amyotrophic lateral sclerosis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Prematurely Ended) IE (Completed) BE (Completed)

Trial results: View results

EudraCT Number: 2011-006119-70

Sponsor Protocol Number: 223AS304

Start Date*: 2012-05-15

Sponsor Name:Biogen Idec Research Limited

Full Title: An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis

Medical condition: Amyotrophic Lateral Sclerosis (ALS)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10029205 - Nervous system disorders	10002026	Amyotrophic lateral sclerosis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Prematurely Ended) IE (Prematurely Ended) ES (Prematurely Ended) BE (Prematurely Ended) NL (Prematurely Ended) GB (Prematurely Ended) DE (Completed)

Trial results: View results

EudraCT Number: 2011-000520-15

Sponsor Protocol Number: B1821010

Start Date*: 2011-09-29

Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017

Full Title: A MULTICENTER, OPEN LABEL STUDY TO COMPARE ON DEMAND TREATMENT TO A PROPHYLAXIS REGIMEN OF NONACOG ALFA (BENEFIX) IN SUBJECTS WITH MODERATELY SEVERE TO SEVERE HEMOPHILIA B (FIX:C ≤2%)

Medical condition: Hemophilia B

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	15.0	10010331 - Congenital, familial and genetic disorders	10060614	Hemophilia B (Factor IX)	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male

Trial protocol: PL (Completed) BG (Completed) GR (Completed) Outside EU/EEA

Trial results: View results

EudraCT Number: 2020-001592-33

Sponsor Protocol Number: 0204

Start Date*: 2020-11-17

Sponsor Name:Rigshospitalet

Full Title: Maternal Mental Health (MAMA) Study. Short time estrogen as a candidate strategy to prevent postpartum depression in a high-risk group

Medical condition: Perinatal depression with postpartum onset

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004873	10056393	Postpartum depression	LLT

Population Age: Newborns, Under 18, Adults

Gender: Male, Female

Trial protocol: DK (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2019-002786-35

Sponsor Protocol Number: CUA1

Start Date*: 2020-06-25

Sponsor Name:Charlotte Uggerhøj Andersen

Full Title: Pharmacokinetics and side effects for tetrahydrocannabinol and cannabidiol (Sativex) among patients with chronic kidney disease and patients on dialysis.

Medical condition: Chronic kidney disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	10038359 - Renal and urinary disorders	10064848	Chronic kidney disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: View results

EudraCT Number: 2008-006831-10

Sponsor Protocol Number: 1199.15

Start Date*: Information not available in EudraCT

Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG

Full Title: Multicenter, randomised, double-blind Phase III trial to investigate the efficacy and safety of BIBF 1120 in combination with carboplatin and paclitaxel compared to placebo plus carboplatin and pac...

Medical condition: Advanced ovarian cancer, fallopian tube cancer or primary peritoneal cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	19.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10026469	Malignant neoplasm of specified parts of peritoneum	LLT
	19.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10026340	Malignant neoplasm of peritoneum, unspecified	LLT
	19.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10016180	Fallopian tube cancer	PT
	19.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10033128	Ovarian cancer	PT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: DE (Completed) FR (Completed) SE (Completed) BE (Completed) PT (Completed) SK (Completed) DK (Completed) AT (Completed) NL (Completed) FI (Completed) PL (Completed) IT (Completed) GR (Completed) CZ (Completed) ES (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2006-000471-14	Sponsor Protocol Number: TRA105325	Start Date*: 2006-06-13
Sponsor Name:GlaxoSmithKline Research and Development Limited
Full Title: EXTEND (Eltrombopag eXTENded Dosing Study): An extension study of eltrombopag olamine (SB-497115-GR) in adults, with idiopathic thrombocytopenic purpura (ITP), previously enrolled in an eltrombopa...
Medical condition: Immune thrombocytopenic purpura (ITP)
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: SI (Completed) SE (Completed) DE (Completed) ES (Completed) IE (Completed) NL (Completed) GR (Completed) FR (Completed) SK (Completed) GB (Completed) CZ (Completed) DK (Completed) IT (Completed) FI (Completed) AT (Completed)
Trial results: View results

EudraCT Number: 2014-000565-47

Sponsor Protocol Number: BAY59-7939/14372

Start Date*: 2014-07-25

Sponsor Name:Bayer HealthCare AG

Full Title: Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age-and body weight-adjusted rivaroxaban regimen compared to standard of care in children with...

Medical condition: Venous Thrombosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.0	100000004866	10066899	Venous thromboembolism	LLT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: ES (Completed) AT (Completed) IT (Completed) NL (Completed) BE (Completed) DE (Completed) GB (Completed) PL (Completed) IE (Completed) FR (Completed) FI (Completed) HU (Completed) SE (Completed) SK (Completed) PT (Completed)

Trial results: View results

EudraCT Number: 2009-013256-69

Sponsor Protocol Number: CQVA149A2304

Start Date*: 2010-04-13

Sponsor Name:Novartis Pharma Services AG

Full Title: A 64-week treatment, multi-center, randomized, double-blind, parallel-group, active controlled study to evaluate the effect of QVA149 (110/50 μg o.d.) vs NVA237 (50 μg o.d.) and open-label tiotropi...

Medical condition: Chronic Obstructive Pulmonary Disease (COPD)

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.1		10010952	COPD	LLT
	12.1		10010953	COPD exacerbation	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) HU (Completed) FI (Completed) CZ (Completed) NL (Completed) SK (Completed) ES (Completed) GB (Completed) DK (Completed) FR (Completed) EE (Completed) IE (Completed) IT (Completed) PL (Completed) AT (Completed) GR (Completed)

Trial results: View results

EudraCT Number: 2005-004094-25

Sponsor Protocol Number: EGD-EC-003

Start Date*: 2006-01-05

Sponsor Name:Astellas Pharma Europe B.V.

Full Title: A phase IIIb randomized study of intermittent versus continuous androgen deprivation therapy using ELIGARD 22.5 mg 3-month depot in subjects with relapsing or locally advanced prostate cancer who a...

Medical condition: Histologically or cytologically confirmed adenocarcinoma of the prostate (PCa) meeting the following criteria: - Locally adv. (stage T3 or T4) PCa, N0 or N+, M0 with PSA >= 5 ng/ml, or - Relapsing ...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.0		10060862		LLT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: CZ (Completed) AT (Prematurely Ended) FI (Completed) SK (Completed) IE (Completed) HU (Completed) DE (Completed) ES (Completed) SE (Completed) GB (Completed) PT (Completed) BE (Completed) DK (Completed) GR (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2008-000498-40

Sponsor Protocol Number: CRAD001N2301

Start Date*: 2009-06-08

Sponsor Name:Novartis Pharma Services AG

Full Title: A randomized, double-blind, placebo-controlled, multicenter phase III study of RAD001 adjuvant therapy in poor risk patients with Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 versus matching pla...

Medical condition: Diffuse Large B-Cell Lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10012818	Diffuse large B-cell lymphoma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed) HU (Completed) SK (Completed) AT (Completed) IT (Completed) DE (Completed) GR (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2007-007942-36

Sponsor Protocol Number: EFC6520

Start Date*: 2008-09-30

Sponsor Name:sanofi-aventis recherche & développement

Full Title: A Multinational, Multicenter, Randomized, Double Blind Study comparing the Efficacy and Safety of AVE5026 with enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major A...

Medical condition: The subjects who will participate to this clinical trial are patients undergoing major abdominal surgery.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10049909	Venous thromboembolism prophylaxis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) ES (Completed) LV (Completed) EE (Completed) DK (Completed) BE (Completed) SE (Completed) HU (Completed) CZ (Completed) LT (Completed) SI (Completed) IT (Completed) SK (Completed) BG (Completed) AT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2016-000814-31

Sponsor Protocol Number: CAIN457F3302

Start Date*: 2016-08-03

Sponsor Name:Novartis Farmacéutica, S.A.

Full Title: MAXIMISE (Managing AXIal Manifestations in Psoriatic Arthritis with SEcukinumab), a randomized, double-blind, placebo-controlled, multicenter, 52 week study to assess the efficacy and safety of sec...

Medical condition: Axial Psoriatic Arthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	100000004859	10037160	Psoriatic arthritis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) CZ (Completed) FR (Completed) GB (Completed) HU (Completed) EE (Completed) IE (Completed) BE (Completed) FI (Completed) DK (Prematurely Ended) DE (Completed) BG (Completed) GR (Completed) PL (Completed) IT (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Informed Consent